Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 9/11/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Robert H. Ring

Wrong Dr. Robert H. Ring?
 
Background

Employment History

  • Chief Science Officer
    Autism Speaks Inc
  • Vice President of Translational Research
    Autism Speaks Inc
  • Senior Director and Head of the Autism Research Unit
    Pfizer Inc
  • President
    Delivering Scientific Innovation for Autism LLC (DELSIA)
  • President and Autism Speaks' Chief Science Officer
    DELSIA
  • President of DELSIA
    DELSIA
  • Chief Science Officer
    AutismSpeaks.org

Education

  • Ph.D. , Molecular Neurobiology
    City of Hope National Medical Center
  • B.A. double major , Fine Art and Biology
    Westmont College
  • Ph.D. , Molecular Neurobiology
    City of Hope
  • B.A. degree , Fine Art and Biology
  • PhD
126 Total References
Web References
Leadership | About Us | Autism Speaks
www.autismspeaks.org, 28 May 2014 [cached]
Rob Ring -- Chief Science Officer
...
Rob Ring, Chief Science Officer
Rob Ring was named Chief Science Officer in June of 2013. Upon his appointment Rob said his first goal would be to "put science to work for our families," and that makes perfect sense given his background. Rob first joined Autism Speaks in June of 2011 as Vice President of Translational Research. In that role, Rob was responsible for the development and implementation of the foundation's expanding translational research portfolio, which serves to accelerate the process of converting scientific breakthroughs and innovations in technology into actual products that address the wide range of unmet needs of the autism community, from healthcare to education to daily living. Rob also serves as President of Delivering Scientific Innovation for Autism (DELSIA), the venture philanthropy arm of Autism Speaks that is helping to facilitate translational activities in the for-profit sector required to develop commercial products that will improve the quality of life and health for individuals with autism.
Prior to joining Autism Speaks, Rob served as Senior Director and Head of the Autism Research Unit at Pfizer Worldwide Research and Development in Groton, Conn. There he led the first dedicated research group in the pharmaceutical industry focused specifically on the discovery and development of medicines for neurodevelopmental disorders, specifically ASD. Prior to Pfizer, Rob worked for over 10 years in psychiatric medicines discovery and development at Wyeth Research in Princeton, N.J.
Rob earned a B.A. double major in both Fine Art and Biology from Westmont College in Santa Barbara, Calif., and a Ph.D. in Molecular Neurobiology from City of Hope in Southern California. He holds adjunct faculty appointments in the Departments of Psychiatry at Mount Sinai School of Medicine (N.Y.) and Pharmacology and Physiology at Drexel University College of Medicine (Philadelphia).
President - Robert H. Ring, ...
www.autismspeaks.org, 4 Oct 2013 [cached]
President - Robert H. Ring, Ph.D.
Dr. Ring holds a dual role as DELSIA's president and Autism Speaks' chief science officer, providing overall leadership for Autism Speaks science programs and initiatives. Prior to joining Autism Speaks in 2011, Dr. Ring served as senior director and head of the Autism Research Unit at Pfizer Worldwide Research and Development, in Groton, Conn. Prior to Pfizer, Dr. Ring gained a decade experience in psychiatric drug discovery and development at Wyeth Research, in Princeton, N.J. Dr. Ring holds adjunct faculty appointments in psychiatry at Mount Sinai School of Medicine and in pharmacology and physiology at Drexel University College of Medicine.
"With the publication of this study, ...
www.eurekalert.org, 24 April 2014 [cached]
"With the publication of this study, we should step back to recognize and celebrate the pioneering achievements of the AGP and what they have accomplished in helping to launch the field of genomic risk discovery in autism," says Autism Speaks Chief Science Officer Rob Ring.
Science Department Leadership | Science | Autism Speaks
www.autismspeaks.org, 28 May 2014 [cached]
Robert Ring, Ph.D. Chief Science Officer
Oxytocin has such a powerful ...
surgicareofwichita.com, 4 Aug 2014 [cached]
Oxytocin has such a powerful effect on social skills that the hormone could prove a very useful treatment for some people with autism, said Rob Ring, chief science officer for the advocacy and research organization Autism Speaks.
...
In the meantime, oxytocin therapy may prove helpful for children with autism and adults whose levels of the hormone are low, Parker and Ring said.
...
SOURCES: Karen Parker, Ph.D., assistant professor, psychiatry, Stanford University School of Medicine, Palo Alto, Calif.; Rob Ring, Ph.D., chief science officer, Autism Speaks; Aug. 4, 2014, Proceedings of the National Academy of Sciences
Other People with the name "Ring":
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304